REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 15th, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations
This Registration Rights Agreement (this “Agreement”) is made and entered into as of ____, 2019 among Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT RELMADA THERAPEUTICS, INC.Security Agreement • May 15th, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________________________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on __________, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), up to _______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
UNIT PURCHASE AGREEMENT BY AND AMONG RELMADA THERAPEUTICS, INC. AND EACH PURCHASER IDENTIFIED ON APPENDIX A HERETO DISCLOSURE SCHEDULES AND EXHIBITS TO UNIT PURCHASE AGREEMENTUnit Purchase Agreement • May 15th, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
This UNIT PURCHASE AGREEMENT (this “Agreement”) is dated as of March ____, 2019 by and among Relmada Therapeutics, Inc., a Nevada corporation (the “Company”), and each purchaser identified on Appendix A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SUBSCRIPTION AGREEMENT To subscribe for Units in the private offering of RELMADA THERAPEUTICS, INC.Subscription Agreement • May 15th, 2019 • Relmada Therapeutics, Inc. • Pharmaceutical preparations • New York
